CVS Health Corp (NYSE:CVS) shares, rose in value on Friday, April 05, with the stock price up by 0.42% to the previous day’s close as strong demand from buyers drove the stock to $74.21.
Actively observing the price movement in the recent trading, the stock is buoying the session at $73.90. The value of beta (5-year monthly) is 0.51 whereas the PE ratio is 11.48 over 12-month period. Referring to stock’s 52-week performance, its high was $83.25, and the low was $64.41. On the whole, CVS has fluctuated by -0.17% over the past month.
With the market capitalization of CVS Health Corp currently standing at about $93.39 billion, investors are eagerly awaiting this quarter’s results, scheduled for May 01, 2024. The company’s Forward Dividend Ratio is 2.48, with its dividend yield at 3.34%. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be $1.71, which is expected to increase to $2.34 for fiscal year $8.3 and then to about $9.19 by fiscal year 2025. Data indicates that the EPS growth is expected to be -5.00% in 2025, while the next year’s EPS growth is forecast to be 10.70%.
Analysts have estimated the company’s revenue for the quarter at $89.26 billion, with a low estimate of $87.42 billion and a high estimate of $91.18 billion. According to the average forecast, sales growth in current quarter could jump up 10.50%, compared to the corresponding quarter of last year. Wall Street analysts also predicted that in 2025, the company’s y-o-y revenues would reach $370.81 billion, representing an increase of 3.60% from the revenues reported in the last year’s results.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were 1 upward and no downward review(s) in last seven days. We see that CVS’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium term indicators have put the stock in the category of 50% Buy while long term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the PEG ratio is about 3.11, with the price of CVS currently trading nearly -3.63% and -2.14% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 39.37, while the 7-day volatility ratio is showing 2.26% which for the 30-day chart, stands at 2.03%. Furthermore, CVS Health Corp (CVS)’s beta value is 0.52, and its average true range (ATR) is 1.77.
A comparison of CVS Health Corp (CVS) with its peers suggests the former has fared considerably weaker in the market. CVS showed an intraday change of 0.42% in today’s session so far, and over the past year, it shrunk by -2.68%%.
Data on historical trading for CVS Health Corp (NYSE:CVS) indicates that the trading volumes over the past 10 days have averaged 10.49 million and over the past 3 months, they’ve averaged 11.28 million. According to company’s latest data on outstanding shares, there are 1.29 billion shares outstanding.
Nearly 0.19% of CVS Health Corp’s shares belong to company insiders and institutional investors own 82.35% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 18.64 million shares as on Mar 15, 2024, resulting in a short ratio of 2.07. According to the data, the short interest in CVS Health Corp (CVS) stood at 1.48% of shares outstanding as of Mar 15, 2024; the number of short shares registered in Feb 15, 2024 reached 30.76 million. The stock has fallen by -6.02% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CVS stock heading into the next quarter.
